下载App
扫码立即下载
  • 下载App

    扫码立即下载

  • 在线客服

    登录后咨询在线客服
+
恭喜您!
成功领取价值超 5000港元/年的高级行情
前往体验 >>

Progyny (NASDAQ:PGNY) Issues Earnings Results
纳斯达克(Sequoia Capital:PGNY)发布财报

kopsource ·  {{timeTz}}

Progyny (NASDAQ:PGNY – Get Rating) issued its quarterly earnings data on Thursday. The company reported $0.09 EPS for the quarter, topping analysts' consensus estimates of $0.05 by $0.04, Briefing.com reports. Progyny had a net margin of 7.39% and a return on equity of 18.11%. The firm had revenue of $195.00 million for the quarter, compared to analyst estimates of $190.51 million. During the same quarter in the previous year, the business posted $0.19 EPS. The firm's revenue was up 51.5% compared to the same quarter last year.

纳斯达克(股票代码:PGNY-GET Rating)周四发布了季度收益数据。据Briefing.com报道,该公司公布本季度每股收益为0.09美元,比分析师普遍预期的0.05美元高出0.04美元。Progyny的净利润率为7.39%,股本回报率为18.11%。该公司本季度营收为1.95亿美元,而分析师预期为1.9051亿美元。在去年同一季度,该业务公布的每股收益为0.19美元。与去年同期相比,该公司的收入增长了51.5%。

Progyny Price Performance

孕期性价比

Shares of PGNY stock opened at $41.15 on Friday. Progyny has a 12 month low of $25.67 and a 12 month high of $68.32. The firm has a market capitalization of $3.78 billion, a P/E ratio of 89.46, a P/E/G ratio of 21.71 and a beta of 1.85. The company's fifty day moving average price is $30.23 and its two-hundred day moving average price is $37.32.

上周五,PGNY股票开盘报41.15美元。Progyny的12个月低点为25.67美元,12个月高位为68.32美元。该公司的市值为37.8亿美元,市盈率为89.46,市盈率为21.71,贝塔系数为1.85。该公司的50日移动均线价格为30.23美元,200日移动均线价格为37.32美元。

Get
到达
Progyny
孕期
alerts:
警报:

Insiders Place Their Bets

内部人士下注

In other Progyny news, Chairman David J. Schlanger sold 1,452 shares of the business's stock in a transaction on Monday, June 27th. The shares were sold at an average price of $31.21, for a total value of $45,316.92. Following the transaction, the chairman now owns 82,548 shares in the company, valued at approximately $2,576,323.08. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. In other news, Chairman David J. Schlanger sold 1,452 shares of the company's stock in a transaction dated Monday, June 27th. The shares were sold at an average price of $31.21, for a total value of $45,316.92. Following the sale, the chairman now owns 82,548 shares in the company, valued at approximately $2,576,323.08. The sale was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, Director Norman Payson sold 6,618 shares of the company's stock in a transaction dated Wednesday, May 11th. The shares were sold at an average price of $33.45, for a total transaction of $221,372.10. Following the completion of the sale, the director now owns 490,828 shares in the company, valued at approximately $16,418,196.60. The disclosure for this sale can be found here. Insiders have sold 41,240 shares of company stock worth $1,291,601 in the last quarter. 14.00% of the stock is owned by corporate insiders.

在Progyny的其他消息中,董事长David J.Schlanger在6月27日星期一的一次交易中出售了1,452股该公司的股票。这些股票的平均价格为31.21美元,总价值为45316.92美元。交易完成后,董事长现在拥有该公司82,548股,价值约2,576,323.08美元。这笔交易是在提交给美国证券交易委员会(Securities&Exchange Commission)的一份文件中披露的,可以通过这个链接访问。在其他新闻方面,董事长大卫·J·施兰格在一笔日期为6月27日星期一的交易中出售了1,452股公司股票。这些股票的平均价格为31.21美元,总价值为45316.92美元。出售后,董事长现在拥有该公司82,548股,价值约2,576,323.08美元。这笔交易是在提交给美国证券交易委员会的一份文件中披露的,可以通过美国证券交易委员会网站访问该文件。此外,在一笔日期为5月11日(星期三)的交易中,董事诺曼·佩森出售了6618股该公司股票。这些股票的平均价格为33.45美元,总成交额为221,372.10美元。出售完成后,董事现在拥有该公司490,828股,价值约16,418,196.60美元。此次拍卖的披露信息可在此处找到。上个季度,内部人士出售了41,240股公司股票,价值1,291,601美元。14.00%的股份由企业内部人士持有。

Institutional Investors Weigh In On Progyny

机构投资者对Progyny的看法

Institutional investors have recently modified their holdings of the stock. Vontobel Holding Ltd. bought a new stake in shares of Progyny during the 1st quarter valued at about $1,969,000. Yousif Capital Management LLC grew its position in shares of Progyny by 1.1% during the 1st quarter. Yousif Capital Management LLC now owns 37,264 shares of the company's stock valued at $1,915,000 after buying an additional 392 shares during the last quarter. Eaton Vance Management grew its position in shares of Progyny by 99.8% during the 1st quarter. Eaton Vance Management now owns 32,071 shares of the company's stock valued at $1,649,000 after buying an additional 16,018 shares during the last quarter. Natixis Advisors L.P. grew its position in shares of Progyny by 47.3% during the 1st quarter. Natixis Advisors L.P. now owns 29,595 shares of the company's stock valued at $1,521,000 after buying an additional 9,497 shares during the last quarter. Finally, Commonwealth of Pennsylvania Public School Empls Retrmt SYS grew its position in shares of Progyny by 10.5% during the 1st quarter. Commonwealth of Pennsylvania Public School Empls Retrmt SYS now owns 25,519 shares of the company's stock valued at $1,312,000 after buying an additional 2,433 shares during the last quarter. Institutional investors and hedge funds own 82.51% of the company's stock.
机构投资者最近调整了对该股的持有量。冯托贝尔控股有限公司(Vontobel Holding Ltd.)在第一季度购买了Progyny的新股,价值约1,96.9万美元。Yousif Capital Management LLC在第一季度将其在Progyny股票的头寸增加了1.1%。Yousif Capital Management LLC现在拥有37,264股该公司股票,价值1,915,000美元,上个季度又购买了392股。伊顿·万斯管理公司在第一季度将其在Progyny的股票头寸增加了99.8%。伊顿·万斯管理公司在上个季度又购买了16,018股,现在拥有32,071股该公司股票,价值1,649,000美元。Natixis Advisors L.P.在第一季度将其在Progyny股票的头寸增加了47.3%。Natixis Advisors L.P.现在持有该公司29,595股股票,价值1,521,000美元,在上个季度又购买了9,497股。最后,宾夕法尼亚州联邦公立学校Empls Retrmt Systems在第一季度将其在Progyny的股票头寸增加了10.5%。宾夕法尼亚州联邦公立学校Empls Retrmt Systems在上个季度额外购买了2433股后,现在拥有该公司25,519股股票,价值1,312,000美元。机构投资者和对冲基金持有该公司82.51%的股票。

About Progyny

关于Progyny

(Get Rating)

(获取评级)

Progyny, Inc, a benefits management company, specializes in fertility and family building benefits solutions for employers in the United States. Its fertility benefits solution includes differentiated benefits plan design, personalized concierge-style member support services, and selective network of fertility specialists.

Progyny,Inc.是一家福利管理公司,专门为美国雇主提供生育和家庭建设福利解决方案。其生育福利解决方案包括差异化福利计划设计、个性化礼宾式会员支持服务和有选择的生育专家网络。

Further Reading

进一步阅读

  • Get a free copy of the StockNews.com research report on Progyny (PGNY)
  • MarketBeat: Week in Review 8/1 – 8/5
  • How to Use High Beta Stocks to Maximize Your Investing Profits
  • Cronos Group Inc's Revenues Are Up, Is It Time to Buy?
  • Why Apple Could Be At All-Time Highs By Year End
  • Beyond Meat Is Not Beyond Hope, And It's Cheap
  • 免费获取StockNews.com关于Progyny的研究报告(PGNY)
  • MarketBeat:回顾中的一周8/1-8/5
  • 如何利用高贝塔系数股票最大化你的投资利润
  • 克罗诺斯集团(Cronos Group Inc.)营收上升,是时候收购了吗?
  • 苹果为何可能在年底创下历史新高
  • Beyond Meat不是没有希望,而且它很便宜

Receive News & Ratings for Progyny Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Progyny and related companies with MarketBeat.com's FREE daily email newsletter.

接受Progyny Daily的新闻和评级-在下面输入您的电子邮件地址,通过MarketBeat.com的免费每日电子邮件时事通讯接收对Progyny和相关公司的最新新闻和分析师评级的每日简要摘要。

本页的译文内容由软件翻译。富途将竭力但却不能保证翻译内容之准确和可靠,亦不会承担因任何不准确或遗漏而引起的任何损失或损害。

风险提示:以上内容仅作为作者或者嘉宾的观点,不代表富途的任何立场,不构成与富途相关的任何投资建议。在作出任何投资决定前,投资者应根据自身情况考虑投资产品相关的风险因素,并于需要时咨询专业投资顾问意见。富途竭力但不能证实上述内容的真实性、准确性和原创性,对此富途不做任何保证和承诺。

回到顶部